Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics. - Wikidata - awgldk - TriplyDB

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

http://www.wikidata.org/entity/Q30444706

about

An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells Platelet effects on ovarian cancer Association of single nucleotide polymorphisms in the MVP gene with platinum resistance and survival in patients with epithelial ovarian cancer Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study.Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence.

P2860

Q24302462-BA7E4735-8713-4A44-B17C-9E5B1FEB08BD Q26829401-F526AB32-0FAB-469C-A0E5-779D822C568B Q36742188-F8B268D7-41B1-43FC-9A63-DAC12CF2EE44 Q37212223-C1660AB8-2F41-4D49-8600-3CD178E4C8E3 Q37335929-E392169A-E200-4773-B977-F56AA72BD3DB Q37709179-20146012-949D-41E6-BF33-052E0D4B4B2B Q38152755-86B91BF4-A196-4F20-B660-8C291C8FC916 Q38851169-9F1B47C2-5817-4A05-AFCA-ACDAE02A192B Q39429469-81445022-06E5-4631-AEF2-2AA9733F3278 Q49887274-5966E20D-4E1C-4CB5-AAAA-AB756F3B9723

P2860

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

http://www.wikidata.org/entity/Q30444706

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@ast

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@en

type

label

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@ast

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@en

prefLabel

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@ast

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@en

P1433

Q30444706-9C0B1E93-262B-473C-B6FC-AEA147E1942C

P1476

Q30444706-6772CDAF-8C41-4E9A-AFFD-EF54F90558AF

P2093

Q30444706-59BBF1DA-B79D-4C02-8067-DBCA8ACB5E85

Q30444706-C842DD39-D90C-4EA8-B5CC-660079B755F3

P2860

Q30444706-0467E5C9-6A92-46DD-80CA-BB5827FEF64F

Q30444706-09FBC9F9-D5C3-4D05-BD8E-02294EE53B4C

Q30444706-0C5BAC29-2019-4623-9AD2-8EAA63A86CA6

Q30444706-10E44342-DAA1-4791-BB9F-79351B2AE38C

Q30444706-1B0D671F-2A67-4035-8340-1596FCD82F90

Q30444706-21FB1792-2437-443F-BF00-D0EC2A00960C

Q30444706-23CD47A6-B496-46FE-B34B-BB67D272FF96

Q30444706-28C67EEC-4959-48F9-B753-DEBBA30A24DF

Q30444706-2EDE307D-9276-42AE-B804-8EC6F2F4F535

Q30444706-2F34EFF9-9014-4BAB-B5DD-90ED20781B4F

P304

Q30444706-D06DC2E7-6906-4ED8-A564-E2A8E07DFD63

P31

Q30444706-6351A1B9-9055-4B36-AF8E-7854AD30BF13

P356

Q30444706-CF05E042-4F3D-413B-90CA-4C3DFC7CDB11

P407

Q30444706-A57C5805-DD71-423C-BBE4-524B3E88B65D

P433

Q30444706-D0767F44-37D6-4BF3-B86F-62AEAD0C24AA

P478

Q30444706-E756933F-1371-42D9-AE43-2FCACB6F8847

P577

Q30444706-8F5B7CA5-944D-43C9-B430-909D66F85510

P698

Q30444706-C424E163-CD16-446D-AAE2-361627D5050D

P921

Q30444706-401948C7-92A5-4376-BC67-FC5DFB50B907

Q30444706-8D2F9591-47FF-42A3-9282-55194EB58878

P356

14656566.8.14.2293

P1433

Expert Opinion on Pharmacotherapy

P1476

Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.

@en

P2093

Amir A Jazaeri

http://www.w3.org/2001/XMLSchema#string

Susan C Modesitt

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.

Phase I study of high-dose epirubicin in platinum-pretreated patients with ovarian carcinoma.

Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study.

Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study.

P304

2293-2305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.14.2293

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17927484

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy